Insiders · MBX

MBX insider transactions

MBX Biosciences Inc. (MBX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MBX

• 6h
  SEC Form 4 filed by Director Pescovitz Ora H.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 6h
  SEC Form 4 filed by Director Heron Patrick J

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 6h
  SEC Form 4 filed by Director Stelzer Laurie

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 6h
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 6h
  SEC Form 4 filed by Director Ryder Steven

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 6h
  SEC Form 4 filed by Director Aynechi Tiba

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 24d
  Chief Medical Officer Azoulay Salomon exercised 70,003 shares at a strike of $11.65 and sold $2,685,515 worth of shares (70,003 units at $38.36) as part of a pre-agreed trading plan (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 27d
  Chief Medical Officer Azoulay Salomon sold $6,824 worth of shares (231 units at $29.54), decreasing direct ownership by 2% to 14,769 units (SEC Form 4) (withholding obligation)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 27d
  President & CEO Hawryluk P. Kent sold $17,931 worth of shares (607 units at $29.54), decreasing direct ownership by 0.08% to 727,667 units (SEC Form 4) (for withholding tax)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 32d
  Director Hoerter Steven L. was granted 11,938 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 44d
  Amendment: SEC Form 4 filed by Hoerter Steven L.

  4/A - MBX Biosciences, Inc. (0001776111) (Issuer)
• 44d
  Amendment: SEC Form 4 filed by Hoerter Steven L.

  4/A - MBX Biosciences, Inc. (0001776111) (Issuer)
• 78d
  SEC Form 3 filed by new insider Smither John W

  3 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 81d
  President & CEO Hawryluk P. Kent bought $525,663 worth of shares (18,500 units at $28.41) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 97d
  President & CEO Hawryluk P. Kent exercised 28,768 shares at a strike of $16.00, increasing direct ownership by 4% to 728,274 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 121d
  Chief Medical Officer Azoulay Salomon was granted 15,000 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 121d
  Chief Financial Officer Bartram Richard was granted 15,000 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 121d
  President & CEO Hawryluk P. Kent was granted 35,250 shares, increasing direct ownership by 5% to 699,506 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 134d
  SEC Form 4 filed by Director Stelzer Laurie

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 134d
  SEC Form 3 filed by new insider Stelzer Laurie

  3 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 192d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 210d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 220d
  President & CEO Hawryluk P. Kent exercised 182,859 shares at a strike of $3.25, increasing direct ownership by 38% to 664,256 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 226d
  President & CEO Hawryluk P. Kent bought $272,790 worth of shares (20,000 units at $13.64) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 227d
  Director Hoerter Steven L. bought $264,984 worth of shares (20,000 units at $13.25) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 247d
  Director Heron Patrick J bought $11,999,988 worth of shares (666,666 units at $18.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Mathers Edward T

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Aynechi Tiba

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Cornelius James M

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Ryder Steven

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Heron Patrick J

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 364d
  SEC Form 4 filed by Director Pescovitz Ora H.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 421d
  Director Pescovitz Ora H. bought $45,312 worth of shares (7,693 units at $5.89), increasing direct ownership by 46% to 24,329 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 422d
  SEC Form 4 filed by Director Hoerter Steven L.

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 424d
  SEC Form 3 filed by new insider Hoerter Steven L.

  3 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 470d
  Director Gordon Carl L bought $2,020,756 worth of shares (190,672 units at $10.60) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 470d
  Director Orbimed Advisors Llc bought $2,020,756 worth of shares (190,672 units at $10.60) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 484d
  SEC Form 4 filed by Chief Medical Officer Azoulay Salomon

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 484d
  SEC Form 4 filed by Chief Financial Officer Bartram Richard

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 484d
  President & CEO Hawryluk P. Kent bought $534,500 worth of shares (50,000 units at $10.69) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Director Mathers Edward T converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Baskett Forest converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Behbahani Ali bought $8,000,000 worth of shares (500,000 units at $16.00) and converted options into 3,114,486 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Chang Carmen converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Florence Anthony A. Jr. bought $8,000,000 worth of shares (500,000 units at $16.00) and converted options into 3,114,486 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Makhzoumi Mohamad converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Walker Paul Edward converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Yang Rick converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Sandell Scott D converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Director Orbimed Advisors Llc converted options into 3,062,215 shares and bought $12,000,000 worth of shares (750,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner New Enterprise Associates 17, L.P. converted options into 3,114,486 shares and bought $8,000,000 worth of shares (500,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Frazier Life Sciences X, L.P. converted options into 3,927,774 shares and bought $10,000,000 worth of shares (625,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Director Cornelius James M converted options into 102,082 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Director Heron Patrick J converted options into 3,927,774 shares and bought $10,000,000 worth of shares (625,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  President & CEO Hawryluk P. Kent converted options into 399,760 shares, increasing direct ownership by 144% to 481,397 units (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Director Aynechi Tiba converted options into 1,386,335 shares and bought $12,000,000 worth of shares (750,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Director Gordon Carl L converted options into 3,062,215 shares and bought $12,000,000 worth of shares (750,000 units at $16.00) (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)
• 625d
  Large owner Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. converted options into 1,790,122 shares (SEC Form 4)

  4 - MBX Biosciences, Inc. (0001776111) (Issuer)